HDV superinfection of chronic hepatitis B leads to rapid progression of liver cirrhosis, but the mechanisms that drive disease pathogenesis are not known. HDV-specific T cells have not been detected in chronic patients and only very few CD8 T cell epitopes were identified in rare recovered patients. Reasoning that a surge in viremia after lonafarnib/ritonavir antiviral therapy may boost T cell responses and facilitate epitope mapping in chronic HDV infection, we established HDV-specific T cell lines from post-treatment bleeds of chronic HDV patients and mapped CD8 T cell epitopes with pools of overlapping HDV peptides and dose titrations of 15-mer and shorter peptides. IFN-gamma production was used as read-out. With this approach, we identified six CD8 T cell epitopes, several of which were restricted by multiple HLA class I alleles. These were used to synthesize MHC-epitope multimers and to characterize HDV-specific CD8 T cells ex vivo in untreated patients. HDV-specific CD8 T cells were as frequent as HBV-specific CD8 T cells but were less frequent than T cells with specificity for cytomegalovirus, Epstein Barr virus, or influenza virus. The ex vivo frequency of activated HDV-specific CD8 T cells correlated with aminotransferase activity as a biomarker for liver inflammation. CD8 T-cell production of interferon gamma after stimulation with HDV peptides correlated inversely with HDV titer. HDV-specific CD8 T cells did not express the terminal differentiation marker CD57, and fewer HDV-specific than Epstein Barr virus-specific CD8 T cells were 2B4+CD160+PD1+, a characteristic of exhausted cells. Approximately half of the HDV-specific CD8 T cells had a memory-like PD1+CD127+TCF1-high Tbet-low phenotype, which associated with HDV sequence variants with reduced HLA-binding and reduced T-cell activation. In conclusion, we have shown that CD8 T cells isolated from patients with chronic HDV and HBV infection recognize HDV epitopes presented by multiple HLA molecules. The subset of activated HDV-specific CD8 T cells targets conserved epitopes and likely contributes to disease progression. The subset of memory-like HDV-specific CD8 T cells is functional but unable to clear HDV because of the presence of viral escape variants.

Project Start
Project End
Budget Start
Budget End
Support Year
22
Fiscal Year
2019
Total Cost
Indirect Cost
City
State
Country
Zip Code
Park, Heiyoung; O'Brien, Thomas R; Rehermann, Barbara (2018) The role of genetics in hepatic fibrosis among hepatitis C virus patients. Hepatology 67:2043-2045
Rehermann, Barbara; Thimme, Robert (2018) Insights From Antiviral Therapy into Immune Responses to HBV and HCV Infection. Gastroenterology :
Bolte, Fabian J; Rehermann, Barbara (2017) Tissue-resident T cells in hepatitis B: A new target for cure? J Exp Med 214:1564-1566
Bolte, Fabian J; O'Keefe, Ashley C; Webb, Lauren M et al. (2017) Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation. Gastroenterology 153:1392-1403.e2
Cheng, Xiaoming; Xia, Yuchen; Serti, Elisavet et al. (2017) Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages. Hepatology 66:1779-1793
Rehermann, Barbara (2017) Mature peritoneal macrophages take an avascular route into the injured liver and promote tissue repair. Hepatology 65:376-379
Block, Timothy M; Locarnini, Stephen; McMahon, Brian J et al. (2017) Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics. Clin Infect Dis 64:1283-1288
Rehermann, Barbara (2016) HCV in 2015: Advances in hepatitis C research and treatment. Nat Rev Gastroenterol Hepatol 13:70-2
Rehermann, Barbara (2016) Peptide-dependent HLA-KIR-mediated regulation of NK cell function. J Hepatol 65:237-9
Gara, Naveen; Abdalla, Adil; Rivera, Elenita et al. (2015) Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults. Clin Infect Dis 60:505-13

Showing the most recent 10 out of 34 publications